Humanigen Inc (fka HGENQ)

[DonDonDonDon]

For instance, the $18B estimate did not factor in government purchases for their national stockpiles. Previous governmental purchase orders for the Regeneron and Lilly mAbs were for potentially 1 million-plus doses of those products, according to an article by Fierce Pharma, which reported on the EUA awarded to GSK/Vir for their mAb, sotrovimab.

It won't be at all surprising if there are purchase orders for 1 million treatments immediately following the EUA. There are no good treatments for hospitalized patients right now. Individual governments each buying $1 billion worth of lenzilumab isn't inconceivable. Humanigen might literally be in a situation where they can't produce enough to keep up with demand.